SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-07-000144
Filing Date
2007-12-06
Accepted
2007-12-06 16:50:11
Documents
3
Period of Report
2007-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENTS TO BYLAWS AND DEFERRED COMP PLAN ligand8k120607.txt 8-K 5718
2 AMENDMENT OF BYLAWS OF LIGAND PHARMACEUTICALS INC. ex3-1.txt EX-3 6002
3 THIRD AMENDMENT TO THE LIGAND PHARMACEUTICALS NONQUALIFIED DEFERRED COMPENSATIO ex10-1.txt EX-10 4661
  Complete submission text file 0000886163-07-000144.txt   18058
Mailing Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117
Business Address 10275 SCIENCE CENTER DRIVE SAN DIEGO CA 92121-1117 8585507500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 071290029
SIC: 2834 Pharmaceutical Preparations